{"id":24704,"date":"2023-11-07T09:02:00","date_gmt":"2023-11-07T09:02:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=24704"},"modified":"2026-03-20T14:39:21","modified_gmt":"2026-03-20T21:39:21","slug":"perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/","title":{"rendered":"Perjeta\uff08\u5e15\u59a5\u73e0\u5355\u6297\uff09\uff1a\u4e00\u79cd\u6709\u524d\u666f\u7684 HER2 \u9633\u6027\u4e73\u817a\u764c\u6cbb\u7597\u836f\u7269"},"content":{"rendered":"<p>HER2\uff08\u4eba\u7c7b\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53 2\uff09\u662f\u4e00\u79cd\u5b58\u5728\u4e8e\u67d0\u4e9b\u7ec6\u80de\uff08\u4f8b\u5982\u4e73\u817a\u7ec6\u80de\uff09\u8868\u9762\u7684\u86cb\u767d\u8d28\uff0c\u5728\u7ec6\u80de\u751f\u957f\u548c\u5206\u88c2\u4e2d\u53d1\u6325\u4f5c\u7528\u3002&nbsp;<\/p>\n\n\n\n<p>\u6709\u65f6\uff0c\u4e73\u817a\u764c\u7ec6\u80de\u53ef\u80fd\u542b\u6709\u8fc7\u591a\u7684 HER2 \u57fa\u56e0\u62f7\u8d1d\uff0c\u5bfc\u81f4\u7ec6\u80de\u8868\u9762 HER2 \u86cb\u767d\u542b\u91cf\u8fc7\u9ad8\u3002\u8fd9\u79cd\u60c5\u51b5\u88ab\u79f0\u4e3a HER2 \u9633\u6027\u4e73\u817a\u764c\u3002\u5173\u4e8e&nbsp;<a href=\"https:\/\/www.cancer.org\/cancer\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-her2-status.html\">15% \u81f3 20%<\/a>&nbsp;\u4e73\u817a\u80bf\u7624\u7684 HER2 \u6c34\u5e73\u8f83\u9ad8\u3002&nbsp;<\/p>\n\n\n\n<p>HER2\u9633\u6027\u764c\u75c7\u7684\u6cbb\u7597\u65b9\u6848\u53ef\u80fd\u5305\u62ec\u624b\u672f\u3001\u653e\u5c04\u6cbb\u7597\u3001\u5316\u7597\u3001\u6fc0\u7d20\u6cbb\u7597\u4ee5\u53ca\u9776\u5411\u6cbb\u7597\uff0c\u4f8b\u5982Perjeta\uff08\u5e15\u59a5\u73e0\u5355\u6297\uff09\u3002\u672c\u6587\u91cd\u70b9\u4ecb\u7ecdPerjeta\u6cbb\u7597HER2\u9633\u6027\u764c\u75c7\u7684\u7597\u6548\uff0c\u5e76\u89e3\u91ca\u8be5\u836f\u7269\u7684\u5de5\u4f5c\u539f\u7406\u548c\u6cbb\u7597\u5e94\u7528\u3002<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u5207\u6362\u76ee\u5f55\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">\u5207\u6362<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#What_Is_Perjeta\" >\u4ec0\u4e48\u662f Perjeta\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#What_Is_Perjeta_Used_For\" >Perjeta \u7684\u7528\u9014\u662f\u4ec0\u4e48\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#How_Does_Perjeta_Work\" >Perjeta \u5982\u4f55\u5de5\u4f5c\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#Dose\" >\u5242\u91cf<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#Side_Effects\" >\u526f\u4f5c\u7528<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#Precautions\" >\u9632\u8303\u63aa\u65bd<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#Cost\" >\u6210\u672c<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Perjeta\"><\/span>\u4ec0\u4e48\u662f Perjeta\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Perjeta\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u67d0\u4e9b\u7c7b\u578b\u4e73\u817a\u764c\u7684\u5355\u514b\u9686\u6297\u4f53\u836f\u7269\u3002\u5b83\u5c5e\u4e8eHER2\u6291\u5236\u5242\u7c7b\u836f\u7269\uff0c\u9776\u5411\u4f5c\u7528\u4e8e\u67d0\u4e9b\u4e73\u817a\u764c\u7ec6\u80de\u8868\u9762\u7684HER2\u86cb\u767d\u3002<\/p>\n\n\n\n<p>\u8fd9\u79cd\u836f\u7269&nbsp;<a href=\"https:\/\/www.fiercepharma.com\/pharma\/fda-approves-perjeta-for-neoadjuvant-breast-cancer-treatment#:~:text=Perjeta%20is%20the%20first%20FDA,)%20HER2%2Dpositive%20breast%20cancer.\">\u7ecf\u7f8e\u56fdFDA\u6279\u51c6<\/a>&nbsp;2012\u5e74\uff0cFDA\u6279\u51c6\u8be5\u836f\u7269\u4e0e\u5176\u4ed6\u836f\u7269\u8054\u5408\u7528\u4e8e\u6cbb\u7597\u5df2\u6269\u6563\u81f3\u8eab\u4f53\u5176\u4ed6\u90e8\u4f4d\uff08\u8f6c\u79fb\u6027\u4e73\u817a\u764c\uff09\u6216\u5c40\u90e8\u665a\u671f\u4e14\u65e0\u6cd5\u624b\u672f\u5207\u9664\u7684HER2\u9633\u6027\u4e73\u817a\u764c\u3002FDA\u8fd8\u6279\u51c6\u8be5\u836f\u7269\u4e0e\u5176\u4ed6\u836f\u7269\u8054\u5408\u7528\u4e8eHER2\u9633\u6027\u4e73\u817a\u764c\u7684\u65b0\u8f85\u52a9\uff08\u672f\u524d\uff09\u6cbb\u7597\u3002<\/p>\n\n\n\n<p>Perjeta \u7684\u6279\u51c6\u57fa\u4e8e&nbsp;<a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02132949\">\u4e34\u5e8a\u8bd5\u9a8c<\/a>&nbsp;\u8fd9\u8868\u660e\u5b83\u53ef\u4ee5\u6709\u6548\u5ef6\u7f13 HER2 \u9633\u6027\u4e73\u817a\u764c\u60a3\u8005\u7684\u75c5\u60c5\u8fdb\u5c55\u5e76\u63d0\u9ad8\u5176\u603b\u4f53\u751f\u5b58\u7387\u3002&nbsp;<\/p>\n\n\n\n<p>\u5728\u4e00\u9879\u7814\u7a76\u4e2d\uff0c\u63a5\u53d7 Perjeta \u8054\u5408\u5316\u7597\u548c\u53e6\u4e00\u79cd HER2 \u6291\u5236\u5242 Herceptin\uff08\u66f2\u59a5\u73e0\u5355\u6297\uff09\u6cbb\u7597\u7684\u60a3\u8005\u4e0e\u4ec5\u63a5\u53d7\u5316\u7597\u548c Herceptin \u6cbb\u7597\u7684\u60a3\u8005\u76f8\u6bd4\uff0c\u5b58\u6d3b\u65f6\u95f4\u66f4\u957f\u3002<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Perjeta_Used_For\"><\/span>Perjeta \u7684\u7528\u9014\u662f\u4ec0\u4e48\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Perjeta \u4e0e\u5176\u4ed6\u836f\u7269\u4e00\u8d77\u4f7f\u7528\uff0c\u4f8b\u5982\u00a0<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/trastuzumab-herceptin\/\">Herceptin<\/a>\u00a0\uff08\u66f2\u59a5\u73e0\u5355\u6297\uff09\u548c\u591a\u897f\u4ed6\u8d5b\uff08<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/docetaxel-taxotere\/\">\u591a\u897f\u4ed6\u8d5b<\/a>\uff09\uff0c\u6cbb\u7597\uff1a<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>\u8f6c\u79fb\u6027\u4e73\u817a\u764c<\/strong>\uff1a\u5df2\u6269\u6563\u81f3\u8eab\u4f53\u5176\u4ed6\u90e8\u4f4d\u7684 HER2 \u9633\u6027\u4e73\u817a\u764c\u3002&nbsp;<\/li>\n\n\n\n<li><strong>\u65e9\u671f\u4e73\u817a\u764c\uff1a<\/strong>&nbsp;\u764c\u75c7\u5fc5\u987b\u4f4d\u4e8e\u6dcb\u5df4\u7ed3\u4e2d\u6216\u5927\u4e8e 2 \u5398\u7c73\u3002<\/li>\n\n\n\n<li><strong>\u5c40\u90e8\u665a\u671f\u4e73\u817a\u764c<\/strong>\uff1a\u65e0\u6cd5\u901a\u8fc7\u624b\u672f\u5207\u9664\u7684 HER2 \u9633\u6027\u4e73\u817a\u764c\u3002<\/li>\n\n\n\n<li><strong>\u65b0\u8f85\u52a9\u6cbb\u7597<\/strong>\uff1aHER2\u9633\u6027\u4e73\u817a\u764c\u5728\u624b\u672f\u524d\u8fdb\u884c\u6cbb\u7597\uff0c\u4ee5\u51cf\u5c0f\u80bf\u7624\u7684\u5927\u5c0f\u5e76\u589e\u52a0\u624b\u672f\u5207\u9664\u6210\u529f\u7684\u673a\u4f1a\u3002<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Perjeta_Work\"><\/span>Perjeta \u5982\u4f55\u5de5\u4f5c\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Perjeta\u9776\u5411\u5e76\u963b\u65ad\u764c\u7ec6\u80de\u8868\u9762\u7684\u86cb\u767d\u8d28HER2\uff0c\u6709\u52a9\u4e8e\u51cf\u7f13\u764c\u7ec6\u80de\u7684\u751f\u957f\u548c\u6269\u6563\u3002<\/p>\n\n\n\n<p>HER2\u901a\u5e38\u4e0e\u5176\u4ed6\u86cb\u767d\u8d28\uff08\u4f8b\u5982HER3\uff09\u76f8\u4e92\u4f5c\u7528\uff0c\u5e76\u6fc0\u6d3b\u764c\u7ec6\u80de\u5185\u90e8\u7684\u4fe1\u53f7\u901a\u8def\uff0c\u4ece\u800c\u4fc3\u8fdb\u7ec6\u80de\u751f\u957f\u548c\u5b58\u6d3b\u3002\u8fd9\u79cd\u6fc0\u6d3b\u53ef\u80fd\u5bfc\u81f4\u764c\u7ec6\u80de\u4e0d\u53d7\u63a7\u5236\u5730\u751f\u957f\u548c\u6269\u6563\u3002<\/p>\n\n\n\n<p>Perjeta \u4e0e HER2 \u86cb\u767d\u7684\u7279\u5b9a\u90e8\u5206\uff08\u79f0\u4e3a\u80de\u5916\u7ed3\u6784\u57df\uff09\u7ed3\u5408\uff0c\u8be5\u90e8\u5206\u4f4d\u4e8e\u764c\u7ec6\u80de\u7684\u5916\u8868\u9762\u3002\u901a\u8fc7\u4e0e\u8be5\u533a\u57df\u7ed3\u5408\uff0cPerjeta \u963b\u6b62 HER2 \u4e0e\u4fc3\u8fdb\u764c\u7ec6\u80de\u751f\u957f\u548c\u5206\u88c2\u7684\u5176\u4ed6\u86cb\u767d\u8d28\u548c\u4fe1\u53f7\u901a\u8def\u76f8\u4e92\u4f5c\u7528\u3002<\/p>\n\n\n\n<p>Perjeta \u8fd8\u53ef\u4ee5\u8bf1\u5bfc\u6297\u4f53\u4f9d\u8d56\u6027\u7ec6\u80de\u6bd2\u6027 (ADCC)\uff0c\u8fd9\u662f\u4e00\u79cd\u62db\u52df\u514d\u75ab\u7ec6\u80de\uff08\u81ea\u7136\u6740\u4f24\u7ec6\u80de\uff09\u6765\u653b\u51fb\u548c\u6740\u6b7b\u88ab Perjeta \u6807\u8bb0\u7684\u764c\u7ec6\u80de\u7684\u8fc7\u7a0b\u3002<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dose\"><\/span>\u5242\u91cf<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u5242\u91cf\u53d6\u51b3\u4e8e\u591a\u79cd\u56e0\u7d20\uff0c\u5305\u62ec\u60a8\u7684\u4f53\u91cd\u3001\u75c5\u53f2\u4ee5\u53ca\u6240\u6cbb\u7597\u4e73\u817a\u764c\u7684\u5206\u671f\u548c\u7c7b\u578b\u3002\u5728\u5f00\u59cb\u4f7f\u7528 Perjeta \u6cbb\u7597\u4e4b\u524d\uff0c\u533b\u7597\u4fdd\u5065\u63d0\u4f9b\u8005\u4f1a\u9996\u5148\u5bf9\u60a8\u8fdb\u884c\u68c0\u6d4b\uff0c\u4ee5\u786e\u5b9a\u60a8\u662f\u5426\u60a3\u6709 HER2 \u9633\u6027\u764c\u75c7\u3002&nbsp;<\/p>\n\n\n\n<p>\u4e00\u822c\u6765\u8bf4\uff0c\u5178\u578b\u7684\u5242\u91cf\u662f 840 \u6beb\u514b\uff0c\u4ee5\u9759\u8109 (IV) \u8f93\u6ce8\u8d85\u8fc7 60 \u5206\u949f\uff0c\u7136\u540e\u6bcf 3 \u5468\u4ee5 420 \u6beb\u514b\uff0c\u4ee5\u9759\u8109\u8f93\u6ce8\u8d85\u8fc7 30 \u81f3 60 \u5206\u949f\u3002Perjeta \u4e0e Herceptin\uff08\u66f2\u59a5\u73e0\u5355\u6297\uff09\u548c\u5176\u4ed6\u5316\u7597\u8054\u5408\u4f7f\u7528\u3002<\/p>\n\n\n\n<p>Perjeta \u7531\u533b\u62a4\u4eba\u5458\u5728\u533b\u9662\u6216\u8bca\u6240\u4ee5\u9759\u8109\u8f93\u6ce8\u65b9\u5f0f\u7ed9\u836f\u3002\u8f93\u6ce8\u65f6\u95f4\u548c\u9891\u7387\u53ef\u80fd\u56e0\u5177\u4f53\u6cbb\u7597\u65b9\u6848\u548c\u60a3\u8005\u53cd\u5e94\u800c\u5f02\u3002\u4e3a\u786e\u4fdd\u5b89\u5168\u6709\u6548\u4f7f\u7528\uff0c\u60a3\u8005\u52a1\u5fc5\u9075\u5faa\u533b\u62a4\u4eba\u5458\u63d0\u4f9b\u7684\u5242\u91cf\u548c\u7ed9\u836f\u8bf4\u660e\u3002&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>\u526f\u4f5c\u7528<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u4e0e\u4efb\u4f55\u836f\u7269\u4e00\u6837\uff0cPerjeta\uff08\u5e15\u59a5\u73e0\u5355\u6297\uff09\u4e5f\u53ef\u80fd\u5f15\u8d77\u526f\u4f5c\u7528\uff0c\u4f46\u5e76\u975e\u6240\u6709\u60a3\u8005\u90fd\u4f1a\u51fa\u73b0\u3002\u4e00\u4e9b\u5e38\u89c1\u7684\u526f\u4f5c\u7528\u5305\u62ec\uff1a<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u8179\u6cfb<\/li>\n\n\n\n<li>\u6076\u5fc3\u548c\u5455\u5410<\/li>\n\n\n\n<li>\u75b2\u52b3<\/li>\n\n\n\n<li>\u8131\u53d1<\/li>\n\n\n\n<li>\u76ae\u75b9\u6216\u76ae\u80a4\u523a\u6fc0<\/li>\n\n\n\n<li>\u8179\u75db<\/li>\n\n\n\n<li>\u808c\u8089\u75bc\u75db<\/li>\n\n\n\n<li>\u5934\u75db<\/li>\n\n\n\n<li>\u98df\u6b32\u4e0b\u964d<\/li>\n\n\n\n<li>\u8d2b\u8840<\/li>\n<\/ul>\n\n\n\n<p>\u66f4\u4e25\u91cd\u7684\u526f\u4f5c\u7528\u53ef\u80fd\u5305\u62ec\uff1a<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u5fc3\u810f\u8870\u7aed<\/li>\n\n\n\n<li>\u8f93\u6db2\u53cd\u5e94<\/li>\n\n\n\n<li>\u611f\u67d3<\/li>\n\n\n\n<li>\u8d85\u654f\u53cd\u5e94\u548c\u8fc7\u654f\u53cd\u5e94<\/li>\n<\/ul>\n\n\n\n<p>\u5982\u679c\u51fa\u73b0\u4efb\u4f55\u8fd9\u4e9b\u526f\u4f5c\u7528\uff0c\u8bf7\u52a1\u5fc5\u7acb\u5373\u901a\u77e5\u533b\u7597\u4fdd\u5065\u63d0\u4f9b\u8005\u3002\u533b\u7597\u4fdd\u5065\u63d0\u4f9b\u8005\u53ef\u80fd\u4f1a\u8c03\u6574\u5242\u91cf\u6216\u63d0\u4f9b\u652f\u6301\u6027\u62a4\u7406\u6765\u63a7\u5236\u526f\u4f5c\u7528\u3002\u5728\u67d0\u4e9b\u60c5\u51b5\u4e0b\uff0c\u53ef\u80fd\u9700\u8981\u505c\u6b62\u6216\u5ef6\u8fdfPerjeta\u6cbb\u7597\uff0c\u4ee5\u9632\u6b62\u8fdb\u4e00\u6b65\u7684\u526f\u4f5c\u7528\u3002<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precautions\"><\/span>\u9632\u8303\u63aa\u65bd<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u6709\u5fc3\u810f\u75c5\u53f2\u6216\u66fe\u63a5\u53d7\u8fc7\u4ee5\u4e0b\u6cbb\u7597\u7684\u4eba&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538187\/#:~:text=Anthracyclines%20are%20drugs%20extracted%20from,effective%20anticancer%20drugs%20to%20date.\">\u84bd\u73af\u7c7b\u836f\u7269<\/a>&nbsp;\u6cbb\u7597\u671f\u95f4\u5e94\u5bc6\u5207\u76d1\u6d4b\u3002<\/li>\n\n\n\n<li>\u6000\u5b55\u6216\u54fa\u4e73\u7684\u5987\u5973\u4e0d\u5e94\u63a5\u79cd Perjeta\uff0c\u56e0\u4e3a\u8fd9\u53ef\u80fd\u4f1a\u5bf9\u5a74\u513f\u9020\u6210\u4f24\u5bb3\u3002<\/li>\n\n\n\n<li>\u5bf9 Perjeta \u6216\u5176\u4efb\u4f55\u6210\u5206\u6709\u8fc7\u654f\u53cd\u5e94\u7684\u4eba\u4e0d\u5e94\u670d\u7528\u6b64\u836f\u3002<\/li>\n\n\n\n<li>\u60a3\u6709\u809d\u810f\u6216\u80be\u810f\u75be\u75c5\u7684\u4eba\u4ecd\u7136\u53ef\u4ee5\u63a5\u53d7 Perjeta\uff0c\u4f46\u53ef\u80fd\u9700\u8981\u989d\u5916\u7684\u76d1\u6d4b\u548c\u8c03\u6574\u5242\u91cf\u3002<\/li>\n\n\n\n<li>\u63a5\u53d7 Perjeta \u6cbb\u7597\u7684\u60a3\u8005\u5e94\u907f\u514d\u63a5\u79cd\u6d3b\u75ab\u82d7\uff0c\u56e0\u4e3a\u5c1a\u4e0d\u6e05\u695a\u60a8\u7684\u8eab\u4f53\u5bf9\u75ab\u82d7\u7684\u53cd\u5e94\u5982\u4f55\u3002<\/li>\n\n\n\n<li>\u60a3\u8005\u5e94\u544a\u77e5\u5176\u533b\u7597\u4fdd\u5065\u63d0\u4f9b\u8005\u5176\u6b63\u5728\u670d\u7528\u7684\u6240\u6709\u836f\u7269\uff0c\u5305\u62ec\u5904\u65b9\u836f\u3001\u975e\u5904\u65b9\u836f\u548c\u8349\u836f\u8865\u5145\u5242\uff0c\u4ee5\u786e\u4fdd\u6ca1\u6709\u4efb\u4f55\u836f\u7269\u4e0e Perjeta \u53d1\u751f\u53cd\u5e94\u3002<\/li>\n\n\n\n<li>\u8ba1\u5212\u63a5\u53d7\u624b\u672f\u7684\u60a3\u8005\u5e94\u544a\u77e5\u5176\u533b\u7597\u4fdd\u5065\u63d0\u4f9b\u8005\u4ed6\u4eec\u6b63\u5728\u670d\u7528 Perjeta\u3002<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>\u6210\u672c<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Perjeta \u9759\u8109\u6ce8\u5c04 (IV) \u6eb6\u6db2\uff08\u6bcf 14 \u6beb\u5347\u542b 420 \u6beb\u514b\uff09\u7684\u4ef7\u683c\u7ea6\u4e3a $5,534 \u7f8e\u5143\u3002\u4e00\u5e74\u7684\u6cbb\u7597\u8d39\u7528\u53ef\u80fd\u8d85\u8fc7 $99,000 \u7f8e\u5143\u3002\u5982\u679c\u60a8\u65e0\u529b\u627f\u62c5\u836f\u7269\u8d39\u7528\uff0c\u60a8\u53ef\u4ee5\u7533\u8bf7\u6298\u6263\u6216\u53c2\u52a0\u7ecf\u6d4e\u63f4\u52a9\u9879\u76ee\u6765\u62b5\u6d88\u8d39\u7528\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>HER2\uff08\u4eba\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53 2\uff09\u662f\u4e00\u79cd\u5b58\u5728\u4e8e\u67d0\u4e9b\u7ec6\u80de\uff08\u4f8b\u5982\u4e73\u817a\u7ec6\u80de\uff09\u8868\u9762\u7684\u86cb\u767d\u8d28\uff0c\u5728\u7ec6\u80de\u751f\u957f\u548c\u5206\u88c2\u4e2d\u53d1\u6325\u4f5c\u7528\u3002.<br \/>\n\u6709\u65f6\uff0c\u4e73\u817a\u764c\u7ec6\u80de\u53ef\u80fd\u542b\u6709\u8fc7\u591a\u7684 HER2 \u57fa\u56e0\u62f7\u8d1d\uff0c\u5bfc\u81f4\u7ec6\u80de\u8868\u9762 HER2 \u86cb\u767d\u8fc7\u591a\u3002.<\/p>","protected":false},"author":26,"featured_media":24705,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[64],"tags":[],"class_list":["post-24704","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-discontinued"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer<\/title>\n<meta name=\"description\" content=\"Find out how Perjeta treats HER2-positive breast cancer. Topics include how the drug works, dosage, side effects, precautions, and cost.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer\" \/>\n<meta property=\"og:description\" content=\"Find out how Perjeta treats HER2-positive breast cancer. Topics include how the drug works, dosage, side effects, precautions, and cost.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-07T09:02:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-20T21:39:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer\",\"datePublished\":\"2023-11-07T09:02:00+00:00\",\"dateModified\":\"2026-03-20T21:39:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/\"},\"wordCount\":979,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg\",\"articleSection\":[\"Discontinued\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/\",\"name\":\"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg\",\"datePublished\":\"2023-11-07T09:02:00+00:00\",\"dateModified\":\"2026-03-20T21:39:21+00:00\",\"description\":\"Find out how Perjeta treats HER2-positive breast cancer. Topics include how the drug works, dosage, side effects, precautions, and cost.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Medication for HER2-positive breast cancer treatment\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Perjeta\uff08\u5e15\u59a5\u73e0\u5355\u6297\uff09\uff1a\u4e00\u79cd\u6709\u524d\u666f\u7684 HER2 \u9633\u6027\u4e73\u817a\u764c\u6cbb\u7597\u836f\u7269","description":"\u4e86\u89e3 Perjeta \u5982\u4f55\u6cbb\u7597 HER2 \u9633\u6027\u4e73\u817a\u764c\u3002\u5185\u5bb9\u5305\u62ec\u836f\u7269\u4f5c\u7528\u673a\u5236\u3001\u5242\u91cf\u3001\u526f\u4f5c\u7528\u3001\u6ce8\u610f\u4e8b\u9879\u548c\u8d39\u7528\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/","og_locale":"zh_CN","og_type":"article","og_title":"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer","og_description":"Find out how Perjeta treats HER2-positive breast cancer. Topics include how the drug works, dosage, side effects, precautions, and cost.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-11-07T09:02:00+00:00","article_modified_time":"2026-03-20T21:39:21+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer","datePublished":"2023-11-07T09:02:00+00:00","dateModified":"2026-03-20T21:39:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/"},"wordCount":979,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg","articleSection":["Discontinued"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/","url":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/","name":"Perjeta\uff08\u5e15\u59a5\u73e0\u5355\u6297\uff09\uff1a\u4e00\u79cd\u6709\u524d\u666f\u7684 HER2 \u9633\u6027\u4e73\u817a\u764c\u6cbb\u7597\u836f\u7269","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg","datePublished":"2023-11-07T09:02:00+00:00","dateModified":"2026-03-20T21:39:21+00:00","description":"\u4e86\u89e3 Perjeta \u5982\u4f55\u6cbb\u7597 HER2 \u9633\u6027\u4e73\u817a\u764c\u3002\u5185\u5bb9\u5305\u62ec\u836f\u7269\u4f5c\u7528\u673a\u5236\u3001\u5242\u91cf\u3001\u526f\u4f5c\u7528\u3001\u6ce8\u610f\u4e8b\u9879\u548c\u8d39\u7528\u3002.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg","width":1280,"height":853,"caption":"Medication for HER2-positive breast cancer treatment"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/perjeta-pertuzumab-a-promising-medication-for-her2-positive-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Perjeta (Pertuzumab): A Promising Medication for HER2-Positive Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Robert Hakim\u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"Robert Chad Hakim \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0c\u5728\u52a0\u5dde\u5317\u5cad\u51fa\u751f\u957f\u5927\u3002\u4ed6\u6bd5\u4e1a\u4e8e\u5a01\u65af\u5eb7\u661f\u5927\u5b66\u9ea6\u8fea\u900a\u5206\u6821\u836f\u5b66\u9662\uff0c\u83b7\u5f97\u836f\u5b66\u5b66\u4f4d\u3002\u5de5\u4f5c\u4e2d\u6700\u8ba9\u4ed6\u611f\u5230\u81ea\u8c6a\u7684\u662f\u79ef\u6781\u63a8\u8fdb\u4e34\u5e8a\u9879\u76ee\uff0c\u4ece\u800c\u6700\u5927\u9650\u5ea6\u5730\u63d0\u5347\u60a3\u8005\u62a4\u7406\u7684\u6548\u679c\u3002\u4ed6\u62e5\u6709\u91cd\u75c7\u76d1\u62a4\u59d4\u5458\u4f1a\u8ba4\u8bc1 (BCCCP)\uff0c\u4e13\u4e1a\u9886\u57df\u5305\u62ec\u91cd\u75c7\u76d1\u62a4\u3001\u836f\u7269\u4fe1\u606f\u3001\u5168\u79d1\u533b\u5b66\u548c\u5fc3\u810f\u75c5\u5b66\u3002\u95f2\u6687\u65f6\uff0c\u4ed6\u559c\u6b22\u65c5\u884c\u3002\u00a0","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"HER2 (human epidermal growth factor receptor 2) is a protein found on the surface of some cells (e.g., breast cells) that plays a role in cell growth and division. Sometimes, breast cancer cells can have too many copies of the HER2 gene, leading to too much HER2 protein on the surface of the cells.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Perjeta-Pertuzumab-A-Promising-Medication-for-HER2-Positive-Breast-Cancer.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/discontinued\/\" rel=\"category tag\">Discontinued<\/a>","rttpg_excerpt":"HER2 (human epidermal growth factor receptor 2) is a protein found on the surface of some cells (e.g., breast cells) that plays a role in cell growth and division. Sometimes, breast cancer cells can have too many copies of the HER2 gene, leading to too much HER2 protein on the surface of the cells.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/24704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=24704"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/24704\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/24705"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=24704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=24704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=24704"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}